We developed a novel vaccine plat form utilizing Bifidobacterium as an antigen delivery vehicle for mucosal
immunization. Genetically modified Bifidobacterium longum displaying Salmonella-flagellin on the cell
surface was constructed for the oral typhoid vaccine